Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy
about
Complications from Stereotactic Body Radiotherapy for Lung CancerOutcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centreVolumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates.Nondosimetric risk factors for radiation-induced lung toxicity.Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.Spinal radiosurgery--efficacy and safety after prior conventional radiotherapyInterstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.Radiation-induced organizing pneumonia after stereotactic body radiotherapy for lung tumor.Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer.The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.Radiation pneumonitis after stereotactic radiation therapy for lung cancer.Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapyStereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital.Analysis of predictive parameters for the development of radiation-induced pneumonitis.Efficacy and safety of stereotactic body radiotherapy using CyberKnife in Stage I primary lung tumor.Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer.Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer.Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives.Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy.[Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer].
P2860
Q26995851-E663E2AA-F1E9-4C07-B319-12ADA533C908Q33582666-17762881-3864-4132-B58A-200F3C218316Q34231941-C589CE82-99A4-4547-933B-180F5290215AQ34499545-44866789-F59C-45A3-B5FE-EA25970DF898Q35456001-5974C5D7-CCD2-4AF1-8DC3-BA755816EBF0Q35670667-32B8BC0C-7E5F-41CA-966F-E7B56CF068DAQ35690484-75AFE51E-EB87-47C6-A81D-C66770DD66C0Q36187134-9005261D-32BF-4C1B-B1C7-12A633947113Q36234741-6A858261-A3AB-4E2C-B8B7-5C12E1F53972Q36734816-E8F109D1-6E50-4E04-854F-69F07FEF2DF1Q36810626-97FBFE0D-6B6D-46C2-94B1-8DC4D278B1AAQ37716623-463826B9-DC96-4B1A-A333-4FBBD24B880DQ38256158-21054912-79F8-4C38-B70E-AD3930ADA6E8Q38757792-919EF46F-BEC3-49D0-893B-D60EEF2DF403Q38871523-555156D4-E06A-4B71-AC2C-AD6CFEF50247Q41595091-F0E73EE7-D706-4D7E-9D2B-CC5B43E0B863Q41701899-5F2D61EE-95AB-4D94-987B-BEEF82CA476EQ42033188-147915FE-60BA-4D9E-A0BF-C8B00E4F956BQ47102747-3D090D4F-F679-4259-9781-913B62FCB297Q47752700-44BD412D-1C8F-4E45-961E-A38246DCBFCEQ52624089-3CEA9A5B-05EC-4B40-A786-2ADD7289DBF9Q55079973-BC8FAB94-AE92-453E-A3E0-06DBB4D8BBC8Q55085494-48D69723-B776-4622-A7D6-8030FA8393E0Q55282076-B8F41CE8-A6AC-4342-8282-1D2C4E4A2D6AQ55315278-E1A6B0F4-323F-4E74-905E-166B0733411CQ55441727-86D93402-EF08-45AF-AD0F-12C872CD191B
P2860
Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prescreening based on the pres ...... fter stereotactic radiotherapy
@ast
Prescreening based on the pres ...... fter stereotactic radiotherapy
@en
type
label
Prescreening based on the pres ...... fter stereotactic radiotherapy
@ast
Prescreening based on the pres ...... fter stereotactic radiotherapy
@en
prefLabel
Prescreening based on the pres ...... fter stereotactic radiotherapy
@ast
Prescreening based on the pres ...... fter stereotactic radiotherapy
@en
P2093
P2860
P356
P1433
P1476
Prescreening based on the pres ...... fter stereotactic radiotherapy
@en
P2093
Akihiro Haga
Atsuro Terahara
Hideomi Yamashita
Keiichi Nakagawa
Kuni Ohtomo
Reiko Wakui
Shino Kobayashi-Shibata
P2860
P2888
P356
10.1186/1748-717X-5-32
P577
2010-05-09T00:00:00Z
P6179
1029235267